Loading... Please wait...

Experimental Immunotherapy Eradicates Women's Late Stage Breast Cancer

Posted by

image by Bru-nO pixaby

A women with late stage breast cancer, given less than five years to live, participates in an experimental T-cell immunotherapy. After several rounds of failed chemotherapy, this experimental trial used the women's own immune cells to target and fight off the tumor, leaving her cancer free for two years. 

This new therapy, though still experimental and expensive, shows a promising outlook for helping other patients with metastatic breast cancer, and other cancers such as prostate and ovarian cancer.

Read More. 

[1]. Sample, Ian, and Jessica Glenza. “Doctors Hail World First as Woman's Advanced Breast Cancer Is Eradicated.” The Guardian, Guardian News and Media, 4 June 2018.



Eagle Biosciences, Inc.
20A NW Blvd., Suite 112
Nashua, NH 03063
Email: info@eaglebio.com
Toll Free: 866-411-8023
International: +617-419-2019